Effects of inhibition of P2Y1 and P2Y12 on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 315-322

  Ramström, Sofia ^a,b   Rånby, Mats ^a,c   Lindahl, Tomas L ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Global Hemostasis Institute MGR AB   (Sweden)

Author keywords

Adenosine diphosphate; Fibrinolysis; Haemostasis; Platelet activation; Platelet aggregation inhibitors; Rheology

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE DIPHOSPHATE; AR C 69931MX; COLLAGEN; COLLAGEN RELATED PEPTIDE; PEPTIDE; PROTEIN TRAP 6; PROTEINASE ACTIVATED RECEPTOR 1; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; CASE REPORT; CELL ACTIVATION; CELL ASSAY; CELL SECRETION; ELASTICITY; FIBRINOLYSIS; FLOW MEASUREMENT; HUMAN; NORMAL HUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BLOCKING; SAMPLING; THROMBOCYTE ACTIVATION;

EID: 0038344835     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00254-8     Document Type: Article

References (31)

1. Gachet C. ADP receptors of platelets and their inhibition. Thromb. Haemost. 86:2001;222-232.
2. Woulfe D., Yang J., Brass L. ADP and platelets: the end of the beginning. J. Clin. Invest. 107:2001;1503-1505.
3. Baurand A., Eckly A., Bari N., Leon C., Hechler B., Cazenave J.P.et al. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb. Haemost. 84:2000;484-491.
4. Leon C., Hechler B., Freund M., Eckly A., Vial C., Ohlmann P.et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest. 104:1999;1731-1737.
5. Baurand A., Raboisson P., Freund M., Leon C., Cazenave J.P., Bourguignon J.J.et al. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur. J. Pharmacol. 412:2001;213-221.
6. Jin J., Kunapuli S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8070-8074.
7. Foster C.J., Prosser D.M., Agans J.M., Zhai Y., Smith M.D., Lachowicz J.E.et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107:2001;1591-1598.
8. Hollopeter G., Jantzen H.M., Vincent D., Li G., England L., Ramakrishnan V.et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 409:2001;202-207.
9. Storey R.F., Sanderson H.M., White A.E., May J.A., Cameron K.E., Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br. J. Haematol. 110:2000;925-934.
10. Clutton P., Folts J.D., Freedman J.E. Pharmacological control of platelet function. Pharmacol. Res. 44:2001;255-264.
11. Oliver J.A., Monroe D.M., Roberts H.R., Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler. Thromb. Vasc. Biol. 19:1999;170-177.
12. Rand M., Lock J., van't Veer C., Gaffney D., Mann K. Blood clotting in minimally altered whole blood. Blood. 88:1996;3432-3445.
13. Muszbek L., Adany R., Mikkola H. Novel aspects of blood coagulation factor XIII: I. Structure, distribution, activation, and function. Crit. Rev. Clin. Lab. Sci. 33:1996;357-421.
14. Bajzar L., Manuel R., Nesheim M.E. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270:1995;14477-14484.
15. Esmon C.T. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J. 9:1995;946-955.
16. Kehrel B. Platelet-collagen interactions. Semin. Thromb. Hemost. 21:1995;123-129.
17. Hoffman M., Monroe D.M.I. A cell-based model of hemostasis. Thromb. Haemost. 85:2001;958-965.
18. L. Bohlin, Method of measuring rheological properties and rheometer for carrying out the method, in PCT (Patent Cooperation Treaty) publication number WO94/08222. 1994.
19. Hansson K., Tengvall P., Lundström I., Rånby M., Lindahl T. Surface plasmon resonance and free oscillation rheometry in combination: a new approach for studies on haemostasis and biomaterials. Biosens. Bioelectron. 17:2002;747-759.
20. Ramström S., Rånby M., Lindahl T. The role of platelets in blood coagulation - effects of platelet agonists and of GPIIb/IIIa inhibitors studied by free oscillation rheometry. Thromb. Res. 105:2002;165-172.
21. Morton L.F., Hargreaves P.G., Farndale R.W., Young R.D., Barnes M.J. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem. J. 306:1995;337-344.
22. Hui K.Y., Jakubowski J.A., Wyss V.L., Angleton E.L. Minimal sequence requirement of thrombin receptor agonist peptide. Biochem. Biophys. Res. Commun. 184:1992;790-796.
23. Ramström A., Fagerberg I., Lindahl T. A flow cytometric assay for the study of dense granule storage and release in human platelets. Platelets. 10:1999;153-158.
24. Lundahl T., Petersson J., Fagerberg I., Berg S., Larsson A., Lindahl T. Impaired platelet function correlates with multi-organ dysfunction. A study of patients with sepsis. Platelets. 9:1998;223-225.
25. Lindahl T.L., Festin R., Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation. Thromb. Haemost. 68:1992;221-225.
26. L. Bohlin, Bearing device, in PCT (Patent Cooperation Treaty) publication number WO98/54475. 1998.
27. Ramström S., Rånby M., Lindahl T. Effects of abciximab on coagulum elasticity measured with free oscillation rheometry. Platelets. 13:2002;355-356. [abstract].
28. Barnes M.J., Knight C.G., Farndale R.W. The use of collagen-based model peptides to investigate platelet-reactive sequences in collagen. Biopolymers. 40:1996;383-397.
29. 12 receptors in platelet-mediated aspects of coagulation. Haematologica. 87(10, Suppl. I):2002;20. [abstract].
30. Lau L.F., Pumiglia K., Cote Y.P., Feinstein M.B. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem. J. 303:1994;391-400.
31. Kim S., Foster C., Lecchi A., Quinton T.M., Prosser D.M., Jin J.et al. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood. 99:2002;3629-3636.